One possible explanation is that certain mutations in RRBP1 may impair its function in protein transport and, therefore, slow tumor progression or they may occur in molecular subtypes that are intrinsically associated with a more favorable prognosis. The gene discussed is RRBP1; the disease is neoplasm.